Molecular Neurobiology · 2024 · 14 citations · 23 references
Life SciencesNeurobiologyNeuroscienceAutophagyMolecular NeuroscienceNeurodegenerationMitochondrial DysfunctionMitochondrial Function In NeuronsMitochondrial Quality ControlMitophagyNeurodegenerative DiseasesParkinson DiseaseAlpha-synuclein AggregationAlpha-synuclein MisfoldingDopaminergic NeurodegenerationDopaminergic Neuron DeathMitochondrial Degradation PathwaysMitochondrial TurnoverMitophagy ImpairmentParkinson Disease Autophagy
Parkinson's disease (PD) is a progressive neurogenerative movement disorder characterized by dopaminergic cell death within the substantia nigra pars compacta (SNpc) due to the aggregation-prone protein α-synuclein. Accumulation of α-synuclein is implicated in mitochondrial dysfunction and disruption of the autophagic turnover of mitochondria, or mitophagy, which is an essential quality control mechanism proposed to preserve mitochondrial fidelity in response to aging and stress. Yet, the precise relationship between α-synuclein accumulation, mitochondrial autophagy, and dopaminergic cell loss remains unresolved. Here, we determine the kinetics of α-synuclein overexpression and mitophagy using the pH-sensitive fluorescent mito-QC reporter. We find that overexpression of mutant A53T α-synuclein in either human SH-SY5Y cells or rat primary cortical neurons induces mitophagy. Moreover, the accumulation of mutant A53T α-synuclein in the SNpc of rats results in mitophagy dysregulation that precedes the onset of dopaminergic neurodegeneration. This study reveals a role for mutant A53T α-synuclein in inducing mitochondrial dysfunction, which may be an early event contributing to neurodegeneration.
23
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.8K citations
Medicine, Neurology, Neuroscience +13
Latha Devi, Vijayendran Raghavendran, Badanavalu M. Prabhu et al. · Journal of Biological Chemistry · 2008 · 1.1K citations · Full text